who medicines strategy - libdoc.who.int - World Health Organization

IMPLEMENTING THE STRATEGY | 137Examples of such partnerships in the past threeyears include:> The development in 2002 of the Handbookon Access to HIV/AIDS Treatment inpartnership with the HIV/AIDS Alliance andUNAIDS.> The project to prequalify manufacturers ofARVs, including generic producers, based inWHO and operating in collaboration with theIPC.> In 1995-2002, the development of acomputerized system for registration,involving original work in Tunisia Pharmacyand Medicines Directorate and subsequentdevelopmental work in the EMEA.Working in line with WHO Strategy– links in the knowledge chain buildingstrengthIn turning to WHO for expert advice onmedicines, countries may request data andstatistics concerning health information andadvice on a wide range of health issues or adviceon new and innovative approaches to longstandingor newly emerging health problems.WHO’s response will be in line with the corporatestrategy of fulfilling its mandate and drawingon the core function to create, synthesize, anddisseminate knowledge through a series of relatedapproaches (Figure 30)> A collaborative project with HAI Africa toimprove the involvement of civil society inpolicy development and implementation incountries in the region.> Collaboration with four WHO CollaboratingCentres to develop materials in relation toTRIPS and to monitor the impact of TRIPS andother trade agreements on public health andaccess to essential medicines.